Viewing Study NCT05176002

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-05-19 @ 12:42 PM
Study NCT ID: NCT05176002
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-19
First Post: 2021-11-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.
Sponsor: Fujian Medical University Union Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Neoplasm View
None Immunotherapy View
None Radiotherapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Esophageal Neoplasm View
None Immunotherapy View
None radiotherapy View
None Surgery View
None Neoadjuvant therapy View